Trial Details
COMPLETEDBasic Information
| Clinical ID | c1175 |
|---|---|
| Identifier | NCT02165215 |
| Trial Title | A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Etrolizumab|DRUG: Placebo |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Orange |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-08-12 |
|---|---|
| Primary Completion Date | 2020-04-06 |
| Completion Date | 2020-04-06 |